Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 6985979)

Published in J Urol on January 01, 1980

Authors

J P Richie, R D Blute, J Waisman

Articles by these authors

(truncated to the top 100)

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA (1998) 5.87

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol (1994) 5.31

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. J Urol (1994) 3.17

Biology and management of bladder cancer. N Engl J Med (1990) 2.60

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst (1994) 2.50

Transperineal magnetic resonance image guided prostate biopsy. J Urol (2000) 2.21

Small renal parenchymal neoplasms: further observations on growth. Radiology (1995) 2.15

The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens. Cancer (1998) 2.14

Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst (1997) 2.07

Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol (2000) 1.86

Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol (1998) 1.73

Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem (2001) 1.72

Urological complications of cyclophosphamide. J Urol (1989) 1.69

Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol (1994) 1.63

Future prospects in prostate cancer. Prostate (1999) 1.53

Gender differences in smoking and risk for oral cancer. Cancer Res (1996) 1.47

Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res (2000) 1.46

Sonography of the male genital tract. AJR Am J Roentgenol (1989) 1.45

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44

Review of an 8-year experience with modifications of endoscopic suspension of the bladder neck for female stress urinary incontinence. J Urol (1990) 1.43

Rational approach to evaluation and management of spontaneous perirenal hemorrhage. Surg Gynecol Obstet (1990) 1.42

Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev (1995) 1.42

Stereotaxic aspiration biopsy in the evaluation of mammographically detected clustered microcalcification. Cancer (1998) 1.42

Short and long-term morbidity of thoracoabdominal incision for nephrectomy: a comparison with the flank approach. J Urol (1999) 1.39

Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol (1998) 1.39

Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage. Int J Radiat Oncol Biol Phys (1999) 1.39

Fine needle aspiration biopsy of proliferative breast disease. Mod Pathol (1995) 1.38

Mentholated cigarettes and smoking habits in whites and blacks. Tob Control (2002) 1.37

Aspiration biopsy of prostate. Urology (1982) 1.32

Giant adrenal myelolipoma and testicular interstitial cell tumor in a man with congenital 21-hydroxylase deficiency. Am J Surg Pathol (1979) 1.31

The determination of glutathione, cyst(e)ine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal Biochem (1987) 1.29

Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology (2004) 1.29

International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol (2001) 1.28

Testicular self-examination. N Engl J Med (1980) 1.27

Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol (2001) 1.27

Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res (1996) 1.23

Papillary (transitional) carcinoma in an ileal conduit. J Urol (1975) 1.19

Subcapsular hematoma of the liver. Nonoperative management. Arch Surg (1972) 1.17

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol (1998) 1.16

Life span profiles of glutathione and acetaminophen detoxification. Drug Metab Dispos (1991) 1.15

Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer. J Urol (2011) 1.14

Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol (2001) 1.14

Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol (1995) 1.13

A cell line (SCABER) derived from squamous cell carcinoma of the human urinary bladder. Int J Cancer (1976) 1.12

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst (1993) 1.12

Aggressive surgical approach to renal cell carcinoma: review of 130 cases. J Urol (1979) 1.12

Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol (2000) 1.11

CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev (1997) 1.10

Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res (1980) 1.09

Urologic complications of appendicitis. Urology (1975) 1.09

Results of inferior vena cava resection for renal cell carcinoma. J Urol (1981) 1.09

Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. Int J Radiat Oncol Biol Phys (1999) 1.08

Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev (1995) 1.08

Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma. J Urol (1984) 1.07

Changing concepts in the treatment of nonseminomatous germ cell tumors of the testis. J Urol (1984) 1.07

Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials. J Clin Oncol (2000) 1.07

Fine-needle aspiration cytology of renal-cell adenocarcinoma metastatic to the breast: A report of three cases. Diagn Cytopathol (1999) 1.07

Malignant melanoma metastatic to the breast: a report of seven cases diagnosed by fine-needle aspiration cytology. Cancer (1998) 1.06

Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics (2000) 1.05

Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA (1983) 1.04

Ureteral obstruction secondary to metastatic tumors. Surg Gynecol Obstet (1979) 1.04

Urinary diversion: the physiological rationale for non-refluxing colonic conduits. Br J Urol (1975) 1.03

A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions. J Urol (2004) 1.03

Cardiovascular studies on copper-deficient Swine: x. The fine structure of the defective elastic membranes. Am J Pathol (1967) 1.03

Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology (1998) 1.02

Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer (1989) 1.01

Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup. Cancer (2001) 1.00

Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J Urol (1994) 0.99

Renovascular hypertension in children. Report of seven cases treated surgically including two cases of renal autotransplantation. Am J Surg (1972) 0.99

Incidentally discovered mass of the adrenal gland. Surg Gynecol Obstet (1986) 0.99

Fine-needle aspiration cytology of desmoplastic malignant melanoma metastatic to the parotid gland: case report and review of the literature. Diagn Cytopathol (2000) 0.99

Transthoracic fine-needle aspiration biopsy of pulmonary spindle cell and mesenchymal lesions: a study of 61 cases. Cancer (2001) 0.99

Urate deposition disease. How is it regulated and how can it be modified? Ann Intern Med (1973) 0.98

The effects of various indwelling ureteral catheter materials on the normal canine ureter. J Urol (1988) 0.98

Carcinoma of the adrenal cortex. Cancer (1980) 0.98

Computerized tomography: how accurate for abdominal staging of testis tumors? J Urol (1982) 0.98

The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996. Cancer (1999) 0.97

Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology. AJR Am J Roentgenol (1985) 0.97

Urologic complications in 718 renal transplant patients. Surgery (1984) 0.97

Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer? J Urol (2001) 0.95

UV irradiation-induced apoptosis leads to activation of a 36-kDa myelin basic protein kinase in HL-60 cells. Proc Natl Acad Sci U S A (1996) 0.95

Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica (1994) 0.95

Fine-needle aspiration cytology of hemangiopericytoma: A report of five cases. Cancer (1999) 0.95

Compact cell blocks. Use for body fluids, fine needle aspirations and endometrial brush biopsies. Acta Cytol (1998) 0.94

Fine-needle aspiration cytology of spindle cell lesions of the breast. Cancer (1999) 0.94

Comparison of the classification by microscopic level (stage) of malignant melanoma by three independent groups of pathologists. Cancer (1977) 0.94

Endometriosis in abdominal scars: a report of three cases diagnosed by fine-needle aspiration biopsy. Am Surg (2001) 0.93

Indwelling double-J ureteral stents for temporary and permanent urinary drainage: experience with 87 patients. J Urol (1984) 0.93

Psychosocial outcomes of breast cancer therapies: lumpectomy versus mastectomy. Psychosomatics (1989) 0.92

Nodular lymphoma with intracellular immunoglobulin. Cancer (1979) 0.92

Urethral adenocarcinoma (possibly originating in the glands of Littre). J Urol (1975) 0.92

Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer (1998) 0.91

Nonpalpable intratesticular masses detected sonographically. J Urol (1995) 0.91

Primary adenocarcinoma of the appendix masquerading as a bladder tumor. Arch Surg (1977) 0.90

The effect of aging on glutathione and cysteine levels in different regions of the mouse brain. Proc Soc Exp Biol Med (1989) 0.90

Fasting-induced depletion of glutathione in the aging mouse. Biochem Pharmacol (1993) 0.90

Glomerulocystic kidney. A hypothesis of origin and pathogenesis. Arch Pathol Lab Med (1977) 0.90

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report. Semin Oncol (2001) 0.89

Spironolactone bodies in an adrenal adenoma. Arch Pathol (1975) 0.89

Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial. Eur J Clin Nutr (2012) 0.89